Respiri Limited researches, develops, commercializes, and sells medical devices in Israel, the United States, and Australia. The company also produces and sells mobile health applications. Its products include AirSonea, a tool to enhance asthma management plans for recording wheezeRATE results, track triggers, symptoms, and medication; and Wheezometer, a portable and non-intrusive asthma monitoring device. The company also offers WHolter, an ambulatory 24-hour recorder, which provides information about wheezing and coughing for patients with nocturnal asthma, COPD, occupational asthma, chronic cough, or allergies; and PulmoTrack that is used in a doctor’s office to measure wheeze rate. In addition, it provides AsthmaSense Cloud software, which keeps the track of symptoms, triggers, lung function measurements, and medication usage, as well as acts as a Web-based portal to access and review the information for various users in real time. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
(RSH:Australian Stock Exchange Ltd)
525 Collins Street
Melbourne, VIC 3000
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735www.isonea.com
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for RSH.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact RESPIRI LTD, please visit www.isonea.com. Company data is provided by Capital IQ. Please use this form to report any data issues.